A combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes

Details for Australian Patent Application No. 2006201410 (hide)

International Classifications

Event Publications

27 April 2006 Application Open to Public Inspection

Published as AU-A-2006201410

27 April 2006 Complete Application Filed

17 July 2008 Assignment before Grant

Metabasis Therapeutics, Inc.; Sankyo Company, Limited The application has been assigned to Metabasis Therapeutics, Inc.

28 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.